To read the full story, subscribe or sign in.

Bio Korea 2024: Curocell CEO points to rise, fall of CAR T trends

May 13, 2024

As South Korea’s Curocell Inc. looks to develop the country’s first homegrown CAR T-cell therapy, CEO Gunsoo Kim highlighted rising and falling trends in the global CAR T development space at Bio Korea 2024.

BioWorld Analysis and data insight Cancer Immune CAR T Asia-Pacific

Today's news in brief

BioWorld

BioWorld briefs for July 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 11, 2025.

Scientific figure illustrating astrocytes and neuron synapse

Glia 2025: Microglial crosstalk could be early Alzheimer’s targeting opportunity

BioWorld

“Loss of synapses and dysfunctional synapses in a region-specific way is important in Alzheimer’s. It’s actually the strongest correlate of cognitive decline, far...

New oral BRD4 inhibitor blocks pathogenic expansion of epithelial progenitors in IPF models

BioWorld Science

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited treatment options. IPF is thought to result from repeated microinjuries...

Ultragenyx hit again, this time with a CRL in rare disease

BioWorld

Manufacturing issues are the latest problem for Ultragenyx Pharmaceutical Inc. to solve after last week’s disappointment in a phase III study to treat brittle...